Jump to ContentJump to Main Navigation
Show Summary Details

Drug Metabolism and Personalized Therapy

Official journal of the European Society of Pharmacogenomics and Personalised Therapy

Editor-in-Chief: Llerena, Adrián

Editorial Board Member: Benjeddou, Mongi / Chen, Bing / Dahl, Marja-Liisa / Devinsky, Ferdinand / Hirata, Rosario D. C. / Hubacek, Jaroslav A. / Ingelman-Sundberg, Magnus / Maitland-van der Zee, Anke-Hilse / Manolopoulos, Vangelis G. / Marc, Janja / Melichar, Bohuslav / Meyer, Urs A. / Nair, Sujit / Nofziger, Charity / Peiro, Ana / Sadee, Wolfgang / Salazar, Luis A. / Simmaco, Maurizio / Turpeinen, Miia / Schaik, Ron / Shin, Jae-Gook / Visvikis-Siest, Sophie / Zanger, Ulrich M.

4 Issues per year


SCImago Journal Rank (SJR) 2015: 0.447
Source Normalized Impact per Paper (SNIP) 2015: 0.524
Impact per Publication (IPP) 2015: 1.329

Online
ISSN
2363-8915
See all formats and pricing
Just Accepted

Issues

BEHAVIOURAL PHARMACOLOGY OF THE SERENIC, ELTOPRAZINE

B. Olivier, / J. Mos, / D.L. Rasmussen,
Published Online: 2011-05-11 | DOI: https://doi.org/10.1515/DMDI.1990.8.1-2.31

About the article

Published Online: 2011-05-11

Published in Print: 1990-06-01


Citation Information: Drug Metabolism and Drug Interactions, ISSN (Online) 2191-0162, ISSN (Print) 0792-5077, DOI: https://doi.org/10.1515/DMDI.1990.8.1-2.31. Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Menno R. Kruk, József Halász, Wout Meelis, and József Haller
Behavioral Neuroscience, 2004, Volume 118, Number 5, Page 1062
[2]
Roger D. Porsolt
Journal of Pharmacological and Toxicological Methods, 2013, Volume 68, Number 1, Page 23
[3]
K. A. Miczek, E. M. Weerts, J. A. Vivian, and H. M. Barros
Psychopharmacology, 1995, Volume 121, Number 1, Page 38
[4]
Anton J. M. Loonen
Pharmaceutisch Weekblad Scientific Edition, 1992, Volume 14, Number 4, Page 206
[5]
B. Olivier, M. Th. M. Tulp, and J. Mos
Human Psychopharmacology: Clinical and Experimental, 1991, Volume 6, Number S1, Page S73
[6]
Viola Fischer, Ulrich Schmitt, Harald Weigmann, Boris v. Keller, Stefan Reuss, Christoph Hiemke, and Norbert Dahmen
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1998, Volume 22, Number 7, Page 1129
[7]
T.A.P. Roeling, J.G. Veening, M.R. Kruk, J.P.W. Peters, M.E.J. Vermelis, and R. Nieuwenhuys
Neuroscience, 1994, Volume 59, Number 4, Page 1001
[8]
Jan G. Veening, Lique M. Coolen, Trynke R. de Jong, Henk W. Joosten, Sietze F. de Boer, Jaap M. Koolhaas, and Berend Olivier
European Journal of Pharmacology, 2005, Volume 526, Number 1-3, Page 226
[10]
Alinde E. Wallinga, Sietse F. de Boer, Ramon A. Granneman, Jaap M. Koolhaas, and Bauke Buwalda
Pharmacology Biochemistry and Behavior, 2009, Volume 94, Number 2, Page 227
[11]
Roger L.H. Pobbe, Erwin B. Defensor, Brandon L. Pearson, Valerie J. Bolivar, D. Caroline Blanchard, and Robert J. Blanchard
Behavioural Brain Research, 2011, Volume 216, Number 1, Page 446
[12]
Klaus A Miczek, Stephen C Maxson, Eric W Fish, and Sara Faccidomo
Behavioural Brain Research, 2001, Volume 125, Number 1-2, Page 167
[13]
Jan Mos, Hans H.M. van Aken, Ruud van Oorschot, and Berend Olivier
European Neuropsychopharmacology, 1996, Volume 6, Number 1, Page 1
[14]
Silvana Chiavegatto and Randy J Nelson
Hormones and Behavior, 2003, Volume 44, Number 3, Page 233
[15]
Sharon B Wigal and Sophie Duong
Expert Opinion on Drug Metabolism & Toxicology, 2011, Volume 7, Number 6, Page 775
[16]
Menno R. Kruk
Neuroscience & Biobehavioral Reviews, 1991, Volume 15, Number 4, Page 527

Comments (0)

Please log in or register to comment.
Log in